Author

Daniel L. Meister

University of WindsorORCID 0000-0002-3561-9757Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Azam Mohammadzadeh· 1 shared Gareth E. LimiD· 1 shared Guy A. RutteriD· 1 shared John Frederick TrantiD· 1 shared Luis Fernando Delgadillo-SilvaiD· 1 shared Samra KhaniD· 1 shared Siyi HeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Azam Mohammadzadeh

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Death and DiseasePeer-reviewedNov 10, 2025

A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: Repurposing drugs to disrupt 14-3-3 protein-BAD interactions

Siyi He, Daniel L. Meister, Samra Khan…·Gareth E. Lim

This paper uses a BRET-based high-throughput screen to identify FDA-approved drugs that disrupt 14-3-3{zeta}BAD interactions, showing potential for colorectal cancer treatment.

5 citations

humanexperimental assay

𝕏 PostBluesky